Key points and suggestions for the update of 2024"Diagnosis and Management Guidelines for Chronic Coronary Syndrome Patients in China"
10.20039/j.cnki.1007-3949.2024.12.001
- VernacularTitle:2024年《中国慢性冠脉综合征患者诊断及管理指南》更新要点和建议
- Author:
Zuyi YUAN
1
Author Information
1. 西安交通大学第一附属医院,陕西省西安市 710061
- Publication Type:Journal Article
- Keywords:
chronic coronary syndrome;
guidelines;
antithrombotic therapy;
lipid-lowering therapy;
special populations
- From:
Chinese Journal of Arteriosclerosis
2024;32(12):1013-1019
- CountryChina
- Language:Chinese
-
Abstract:
The"Diagnosis and Management Guidelines for Chronic Coronary Syndrome Patients in China"published in 2024 was led by the Atherosclerosis and Coronary Heart Disease Group of the Cardiology Branch of the Chinese Medical Association and the Editorial Board of the Chinese Journal of Cardiovascular Diseases,in conjunction with the In-tervention Group,Intravascular Imaging and Functional Group,Cardiovascular Disease Imaging Group,and Basic Science Group.The guideline is the first in China to provide guidance for the diagnosis and management of patients with chronic coronary syndrome(CCS),comprehensively introducing the definition,diagnostic process,treatment strategies,and long-term management of CCS.The guideline aims to improve the prognosis and quality of life by providing the best diagnostic or treatment methods.This article focuses on the antithrombotic therapy,lipid-lowering therapy,and management of spe-cial populations for patients with CCS,further interpreting the updates and recommendations in the guidelines.
